Same Indication

Nivolumab vs Trazodone

Nivolumab vs Trazodone: Overview

This comparison examines the pharmacological differences between Nivolumab and Trazodone.

Mechanism of Action

Nivolumab: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.

Trazodone: Serotonin antagonist and reuptake inhibitor (SARI).

Pharmacokinetics

Half-life: Nivolumab — 27 days; Trazodone — 5-9 hours.

Chemical Properties

Molecular Formula: Trazodone — C19H22ClN5O.

Molecular Weight: Trazodone — 371.8640 g/mol.

Type: Nivolumab — Antibody; Trazodone — Small molecule.